Clinical Trial Update: Phase I/II Clinical Trial of LBL-015 for Injection [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase I/II trial evaluating LBL-015 for injection in patients with advanced malignant tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LBL-015

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Malignant Tumor | Phase 1, Phase 2 | Status: COMPLETED